Keryx Biopharmaceuticals Inc. (KERX) Business Metric Overview - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Keryx Biopharmaceuticals ...

    NASDAQ: KERX · Real-Time Price · USD
    3.36
    0.00 (0.00%)
    At close: Jun 29, 2019, 12:07 AM

    Keryx Biopharmaceuticals Revenue Breakdown

    Period Ending Sep 30, 2018
    Auryxia Revenue 26.59M
    Auryxia Revenue Growth n/a
    License Revenue 1.45M
    License Revenue Growth n/a

    Operating Expense Breakdown

    Period Ending Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue 26.45M 28.71M 25.84M 28.79M 22.75M 24.99M 23.1M 23.04M 20.52M 20.19M 20.81M 21.56M 20.2M 20.76M 18.88M
    Selling, General, and Administrative Revenue Growth -7.86% +11.12% -10.25% +26.56% -8.97% +8.15% +0.30% +12.25% +1.65% -2.98% -3.50% +6.72% -2.68% +9.97% n/a
    Research and Development Revenue 7.9M 8.77M 8.39M 12.63M 9.28M 9.01M 6.76M 6.18M 8.67M 7.03M 7.62M 7.99M 11.15M 7.96M 9.59M
    Research and Development Revenue Growth -10.01% +4.60% -33.58% +36.15% +2.92% +33.23% +9.38% -28.71% +23.40% -7.71% -4.68% -28.34% +40.02% -16.97% n/a

    Add to Watchlist